claim: investigational cdk4/6 inhibitor abemaciclib can increase its metabolism when combined with abatacept and decrease when combined with acetazolamide.
article_headline: abemaciclib: uses, interactions, mechanism of action | drugbank online
initial_claim: investigational cdk4/6 inhibitor abemaciclib is active against a range of cancer types